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Abstract 42 
 43 
A novel virulence factor, duodenal ulcer promoting gene A (dupA) in Helicobacter pylori 44 
has been found to be associated with disease in certain population but not in others. The 45 
debate of relevance of dupA for the prediction of clinical outcome has prompted us to take 46 
this study in South East Indian population. A total of 140 H. pylori strains isolated from 47 
duodenal ulcer (DU) [n=83] and non-ulcer dyspepsia (NUD) subjects (n=57) were screened 48 
by PCR and Dot-Blot to determine the presence of jhp0917 and jhp0918. Part of jhp0917-49 
0918 was sequenced to search for the C/T insertion that characterizes dupA and was also 50 
tested for dupA transcript. PCR and Dot-Blot results indicated presence of jhp0917-0918 in 51 
37.3% (31/83) and 12.2% (7/57) of H. pylori strains isolated from DU and NUD, 52 
respectively. Sequencing analysis showed an insertion of ‘C’ at position 1386 in 3’region of 53 
jhp0917 forming dupA gene in 35 strains. RT-PCR analysis detected dupA transcript in 28 54 
out of 35 strains. Expression level of dupA transcript varies from strain to strain as shown by 55 
Real Time PCR. Our study demonstrated that only PCR based analysis for dupA may furnish 56 
erroneous interpretation. Prevalence of dupA was significantly greater among strains isolated 57 
from patients with DU than NUD (P=0.001, OR=4.26, CI=1.60-11.74) in this population. 58 
Based on our finding, dupA can be considered as one of the biomarkers for DU patients in 59 
India. The reported discrepancy for this putative virulence-marker in different populations 60 
may be due to the genome plasticity of H. pylori.  61 
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Introduction  75 
 76 
Helicobacter pylori is a gram-negative, spiral pathogen that infects more than 50% 77 
of the world's population (Brown et al., 2000). Infection with H. pylori plays an important 78 
role in development of peptic ulcer disease, distal gastric carcinoma and gastric mucosa-79 
associated lymphoid tissue lymphoma (Megraud & Lamouliatte, 1992; Parsonnet et al., 80 
1991; Wotherspoon et al., 1991). In India, around 65-70% populations are infected with the 81 
H. pylori (Graham et al., 1991; Singh et al., 2002). Overall, 15-20% of infected patients 82 
develop gastric or duodenal ulcer (DU) and less than 1% develop gastric adenocarcinoma. 83 
H. pylori infection is more prevalent in developing countries, and its incidence is decreasing 84 
in western countries (Czinn et al., 2005). The decisive factor(s) of H. pylori-mediated 85 
infection is still unclear. However, involvement of several virulence factors of the bacteria, 86 
host genetics and environmental influences are believed to determine the outcome of the 87 
infection. Among the host factors, pro-inflammatory cytokine gene polymorphisms have 88 
been associated with DU and gastric carcinoma (GC) (EI-Omar et al., 2000; Machado et al., 89 
2001; Rocha et al., 2005). 90 
Several bacterial virulence genes such as vacA, cagA, babA and oipA of H. pylori 91 
have been investigated to understand their association with gastroduodenal diseases 92 
(Covacci et al., 1993; Atherton et al., 1995; Yamoka et al., 1999, 2000, 2002; Argent et al., 93 
2004). One possible problem that has complicated identification of definite disease-specific 94 
H. pylori virulence factors is the considerable geographic diversity in the prevalence of H. 95 
pylori virulence factors. Cytotoxin-associated gene (cagA) was the first reported gene that 96 
varies in H. pylori strains and considered as a marker for the presence of the cag 97 
Pathogenecity Island (cag-PAI), which include a number of other genes associated with 98 
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increased virulence (Broutet et al., 2001; Cenini et al., 1996; Rahman et al., 2003). 99 
However, none of the above mentioned virulence factors have exhibited any discriminating 100 
roles in the development of peptic ulcer versus GC. In addition to the cag-PAI, comparison 101 
of whole genome of two unrelated H. pylori (J99 and 26695) (Alm et al., 1999; Tomb et al., 102 
1997), indicated presence of a hypervariable region called ‘plasticity zone’ with low  G+C 103 
content along with strain specific open reading frames (ORFs). This plasticity region is 45 104 
kb long, continuous in strain J99 and 68 kb discontinuous in strain 26695. As compared to 105 
38 ORFs of the plasticity zone (jhp0914-jhp0951) in strain J99, 33 were absent in strain 106 
26695) (Yamaoka., 2008; Pacheco et al., 2008; Yakoob et al., 2010; Kersulyte et al., 2003; 107 
Occhialini et al., 2000). Recently, a novel duodenal ulcer promoting gene (dupA) was 108 
described, which consists of two ORFs jhp0917 and jhp0918 and form one continuous gene 109 
by the insertion of a base T or C after the position 1385 of the jhp0917 in the 3' region (Lu et 110 
al., 2005). This gene (homologues to virB4) is located in the plasticity region and is 111 
associated with increased risk of DU and protective against gastric atrophy, intestinal 112 
metaplasia and gastric carcinoma in Japan and Korea (Lu et al., 2005).  113 
However, the role of dupA as a virulence marker is still controversial. Some 114 
researchers have supported the interpretations of Lu et al. (2005)
 
but others did not find any 115 
association. Hussein et al. (2008) have reported that dupA gene is associated with peptic 116 
ulcer but they did not find any negative association with GC in Iraqi population.
 
In Chinese 117 
and north Indian populations significant association of dupA with DU was established 118 
(Zhang et al., 2008; Arachchi et al., 2007). In contrast, Argent et al. (2007) showed no 119 
association of dupA gene with DU in population from Belgium, South Africa, China and the 120 
United States. Douraghi et al. (2008) showed no association of dupA gene with any clinical 121 
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outcome in Iranian population. Schmidt et al. (2009) identified no consistent association 122 
between dupA and DU or GC across the Swedish, Australian and ethnic Chinese, Indian and 123 
Malaysian population residing in Singapore and Malaysia. Meta-analysis based study by 124 
Shiota et al. (2010) has shown that the presence of dupA gene was significantly associated 125 
with DU.
 
Another systematic review confirmed that dupA was associated with 126 
gastroduodenal diseases (Hussein, 2010). 127 
There are also indications of significant geographic differences among strains. Indian 128 
H. pylori strains are genetically distinct than East Asian and Western strains 129 
(Mukhopadhyay et al., 2000). Moreover, our recent study showed that presence of strains 130 
with intact cag Pathogenicity Island was found more frequently in Kolkata than in Southern 131 
India indicating regional variation in the H. pylori gene pools (Patra et al., 2011). These 132 
considerations and our interest in the dynamics of genetic traits associated with H. pylori 133 
infection and disease association motivated us to conduct the present study for investigating 134 
the prevalence of dupA gene of H. pylori in duodenal ulcer and NUD patients isolated from 135 
South East Indian population and also to find out the association of dupA with the clinical 136 
outcome in a different setting. 137 
 138 
Materials and Methods 139 
Collection of Biopsy samples: 140 
A total of 221 adult subjects of both genders (aged between 20 and 65 years) with 141 
upper gastrointestinal disorder underwent endoscopy at the hospital of the Institute of Post 142 
Graduate Medical Education and Research, Kolkata, and St. John's Medical College Hospital, 143 
Bangalore, India during the year 2006 to 2008. A detailed patient’s history was taken, and a 144 
physical examination of each subject was carried out prior to endoscopy. The objective of the 145 
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study was explained to every individual and the informed consents were obtained from each 146 
individual under protocols approved by the ethical committees of the respective institutes 147 
based on the Helsinki Declaration. During endoscopy, two biopsies, one from antrum and the 148 
other from corpus of the stomach, were obtained from each subject. Biopsies taken in 0.6 ml 149 
of Brucella broth (Difco Laboratories, Detroit, MI) with 15% glycerol were transported to the 150 
laboratory in ice-cold condition and were stored at -70°C until culture. 151 
H. pylori Culture:  152 
In the laboratory, Brucella broth containing the specimen was vortexed for 2 min and 153 
200 µl of the mixture was streaked on Petri plates containing brain heart infusion (BHI) agar 154 
(Difco Laboratories) supplemented with 7% sheep blood, 0.4% IsoVitaleX, amphotricin B 155 
(8µg/ml) (Sigma Chemicals Co., St. Louis, MO), trimethoprim (5µg/ml), vanacomycin 156 
(6µg/ml) (Sigma Chemicals) and Nalidixic acid (8µg/ml) (all from Sigma). Plates were 157 
incubated for 3 days at 37
0
C in a double gas incubator (Heraeus Instrument, Germany) which 158 
maintains an atmosphere of 5% O2, 10% CO2 and 85% N2. . The H. pylori colonies were 159 
identified by their typical colony morphology, appearance on Gram staining and positive 160 
reactions in urease, catalase and oxidase tests along with the urease PCR. Bacteria were sub 161 
cultured at 37
0
C on the above medium and under the same microaerophilic condition. 162 
Extraction of genomic DNA: 163 
Cells were harvested from the culture plates and washed with phosphate-buffer 164 
saline (pH 8.0) followed by centrifugation at 3000rpm for 1min. The pelleted cells were 165 
resuspended in 540µl of TE buffer (10mM Tris-HCL, 1mM EDTA), 60µl of 10% Sodium 166 
dodecylsulfate (SDS) (Sigma) and 9µl of Proteinase K (20mg/ml) (Invitrogen, Carlsbad, 167 
CA), mixture was incubated at 50ºC for 1 hour followed by addition of 100µl of 5M NaCl, 168 
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80µl of 10% CTAB solution and then again incubated at 65ºC for 10 minutes. The DNA was 169 
extracted according to the standard phenol-chloroform-method (Ausubel et al., 1993) 170 
 171 
PCR amplification: 172 
PCR amplification was performed in a final volume of 20 µl containing template 173 
DNA (2-20 ng), 2 µl of 10x Buffer (Roche, Germany), 2.5mM dNTPs (Roche) and 10 pmol 174 
of corresponding primers in the presence of 1U of Taq DNA Polymerase (Catalog no. 175 
11435094001, Roche). The cycling program has the following condition: initial denaturation 176 
at 95ºC for 3 min followed by 30 cycles of denaturation at 94ºC for 1 min, annealing at 55ºC 177 
for 1 min, extension at 72ºC for 1 min, and final extension at 72ºC for 7 min. Genomic DNA 178 
from the strain J99 and 26695 were included as positive and negative control respectively. 179 
The PCR products were analyzed by 1.5% agarose gels (containing 0.5 µg of ethidium 180 
bromide per ml) in 1X TAE buffer. Gels were scanned under UV light and analyzed with 181 
Quantity One software (Bio-Rad, Hercules, CA).  The size of product was confirmed by 182 
using DNA molecular size standard. 183 
 184 
Dot-Blot Hybridization: 185 
Dot-Blot was performed using the DNA extracted from all the strains to avoid false-186 
negative results in PCR assay due to variation in the primer annealing sites. About 50 ng of 187 
purified DNA in 2 µl volume was spotted individually onto the Hybond N
+ 
membrane 188 
(Amersham Biosciences, U.K). The membrane was gently placed on 2ml of denaturation 189 
solution for 5 min; enough care was taken to avoid drowning of the membrane into the 190 
solution. The membrane was subsequently treated with 2 ml of neutralization solution for 5 191 
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min. Following neutralization, the membrane was air dried, and UV-cross linked (Bio-Rad). 192 
Parts of jhp0917 and jhp0918 were amplified by PCR using the primer sets 193 
Jhp0917F/jhp0917R and jhp0918F/jhp0918R respectively. (Table 1). The amplified 194 
fragments were purified with, QIAquick PCR Purification kit (QIAGEN, Germany) and 195 
used as a probe. The probes were labeled with alkaline phosphatase using the Gene image 196 
Alkphos Direct Labelling and Detection System (Amersham Biosciences). The membrane 197 
was then used for hybridization with DNA probes at 55ºC overnight and then washed with 198 
primary wash buffer having pH 7 and Magnesium salt 1 mM two times at 55°C for 10 mins 199 
each. Hybridization Blot was again washed with secondary wash buffer having pH 10 with 2 200 
mM Magnesium salt twice at room temperature for 5 mins each and then finally developed. 201 
Based on the signal intensity as detected for positive and negative controls, presence or 202 
absence of genes in the test strains was assigned. 203 
 204 
Nucleotide sequencing: 205 
The intergenic region between jhp0917 and jhp0918 of 38 strains was amplified using four 206 
sets of primers: DupAsetIF/DupAsetIR; DupAsetIIF/DupAsetIR; DupAsetIIF/918R and 207 
DupAsetIF/DupAR (Table 1). The amplified products were purified using the QIAquick 208 
PCR Purification Kit (QIAGEN). The purified PCR product was quantified on 1% agarose 209 
Gel. The intensity of the band compared with λ hind III digest. The PCR purified products 210 
were sequenced with a Big Dye Terminator v3.1 cycle sequencing kit on an ABI PRISM 211 
3100 genetic Analyzer (Applied Biosystem, USA). The sequences obtained in this study 212 
were deposited in GenBank under accession numbers: JN379045-JN379050. 213 
 214 
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Gene expression assay by RT-PCR   215 
Total RNA of H. pylori was isolated with TRIzol reagent (Invitrogen, USA) according to the 216 
manufacturer’s protocol and treated with DNase I (Ambion, USA) to remove DNA 217 
contamination. The absence of DNA contamination was checked by PCR with primer set 218 
ureBF/ureBR (Table 1) and quantified by measuring the absorbance at 260nm. 2µg of total 219 
RNA was reverse transcribed into cDNA with the RevertAid first strand cDNA synthesis kit 220 
(Fermentas, EU).  The cDNA was then amplified with two different primer sets set5F/set5R, 221 
jhp0917F/jhp0917R (Table 1). All the cDNA samples were amplified with ureBF/ureBR 222 
(table1) to check the integrity of cDNA formed. Real time PCR was carried out in 12µl final 223 
volume with the step one plus (Applied Biosystem, USA) under the following the condition 224 
containing 75ng of cDNA, 10pmol each primer dupAsetIF/dupAsetIR, rpsTF/rpsTR (table 225 
1) and Power SYBR Green master mix (Applied Biosystem, U.K). Polymerase activation at 226 
95°C for 5 min followed by 40 cycle at 95°C for 15s, 55°Cfor 30s, and 62°C for 30s. 227 
Threshold cycle number (CT) of triplicate reactions was determined using the stepone 228 
software v2.1, and the mean CT of triplicate reactions was determined. The internal control 229 
gene rpsT was amplified simultaneously in separate reaction tubes under same condition. 230 
The levels of expression of the dupA genes were normalized against rpsT as ∆CT = CT dupA- 231 
CT rpsT. The relative expression of dupA gene in H. pylori strains were calculated as 2
-∆∆C
T, 232 
where -∆∆CT = ∆CT (sample) - ∆CT (reference).  Strain I-77 was used as reference in the real 233 
time PCR assay.  234 
Statistical analysis: A univariate analysis was performed to determine the risk of dupA in 235 
relation to clinical outcome.  For univariate analysis, χ2 test was used. A Probability levels 236 
(P) value of ≤ 0.05 was considered statistically significant. 237 
 10 
Result: 238 
A total of 140 H. pylori strains were isolated from the enrolled 221 subjects, who 239 
underwent endoscopy. Subject with abdominal discomfort, acidity, loss of appetite but no 240 
frank ulceration was considered as non-ulcer dyspepsia (NUD) but those have visible 241 
duodenal ulceration endoscopically were considered as duodenal ulcer (DU) patients. These 242 
strains were isolated from the following two groups: (i) 83 DU patients and (ii) 57 NUD. 243 
Out of 83 (51 male and 32 female) DU cases, the mean age difference was 46 ± 10.72 and 244 
43.7 ± 9.36 and among 57 (36 male and 21 female) NUD, the mean age difference was 32.4 245 
± 7.22 and 33.13 ± 6.84 respectively. The genomic DNA from these 140 strains was used 246 
for further PCR based analysis. 247 
Distribution of jhp0917, jhp0918 , cagA and vacA: 248 
We first studied the presence of jhp0917 and jhp0918 in 140 strains from South East 249 
India, (83 with DU and 57 with NUD) using PCR and dot blot hybridization.  Jhp0917 was 250 
targeted with the specific primers jhp0917F/jhp0917R that yielded 307-bp amplicon. 251 
Similarly, jhp0918 was also amplified with the gene specific primers jhp0918F/jhp0918R 252 
having amplicon size of 276-bp [Table 1 and Fig 1]. All strains that were positive for both 253 
the jhp0917 and the jhp0918 PCR were also positive in the dot blot hybridization. In 254 
addition, 5 PCR negative strains showed positive by dot blot due to strong binding of the 255 
probe (Fig 2). Hybridization results inferred that the interpretation of jhp0917 and jhp0918 256 
positivity should not be considered only based on PCR result (Fig 2). All PCR and Dot-Blot 257 
Hybridization data indicated absence of both jhp0917 and jhp0918 in 68.5% (96/140) strains 258 
isolated from South-East India. Among the positive strains, three strains were positive only 259 
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for jhp0917 and other three strains were positive only for jhp0918. Thus, PCR and Dot-Blot 260 
Hybridization results showed that 38 strains had both the ORFs. 261 
 The cagA and vacA status were determined using primers and protocols described 262 
earlier (Mukhopadhyay et al, 2000; Chattopadhyay et al. 2004). cagA was present in 92.1% 263 
(129/140) of the tested strains from this region. 70% (98/140) of the strains had vacA s1m1 264 
allele. Other two alleles s1m2 and s2m2 of vacA were present in 17.1% (24/140) and 12.8% 265 
(18/140), respectively. Status of cagA and vacA gene in jhp0917-0918 positive 38 strains 266 
isolated from South East Indian population was 34/38 (89.4%) and 22/38 (57.8%) 267 
respectively. Four strains isolated from DU patients were positive for jhp0917-0918 but 268 
negative for cagA and had s2m2 allele of vacA. 269 
Sequencing analysis 270 
Four different primer sets were used for sequencing a small fragment of jhp917 gene to 271 
search one base insertion that characterize dupA as single PCR set was unable to yield PCR 272 
fragment from all 38 strains. Using these four sets of primers, junction region of all the 273 
jhp0917-jhp0918 positive 38 strains were sequenced and compared with the published 274 
sequence of strain J99 (GenBank access AE001439). We observed an insertion of C after 275 
position 1385 in the 3’region of jhp0917 gene in 35 out of 38 clinical isolates. The 276 
remaining three isolates were same as J99 where no insertion of either T or C was found but 277 
still these strains were PCR and dot-blot positive with the primers described earlier 278 
indicating these were not the true dupA (Fig 3).  279 
Expression of dupA 280 
We performed the RT-PCR of 35 dupA positive strains and found that dupA 281 
transcript was present in 28 strains and absent in remaining 7 strains indicating that dupA 282 
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gene was not expressed in all strains (Fig 4A). Real time PCR were done with randomly 283 
selected dupA positive strains and we found that level of dupA transcript varies in different 284 
strains (Fig 4B).  285 
dupA status from South-East Indian Population 286 
In our study, 38 (31 DU and 7 NUD) clinical strains were positive for jhp0917-0918 287 
by PCR and dot-blot hybridization. We found by sequencing that 35 strains had insertion of 288 
C and three strains had no insertion of C/T like J99. During analysis by RT-PCR, we found 289 
that 28 strains out of 35 were positive in the RT-PCR. On the basis of sequencing and RT-290 
PCR findings, we confirm that 28 (23 duodenal ulcer and 5 NUD) strains were dupA 291 
positive and 7 (5 duodenal ulcer and 2 NUD) strains were negative for dupA. Our study 292 
showed that the prevalence of dupA in duodenal ulcer patients 23/83 (27.7%) was 293 
significantly higher than the NUD 5/57 (8.7%). [P=0.001, OR= 6.49, 95% CI=1.71-28.94].  294 
Discussion 295 
Recent studies have proposed the possibility of using genetic markers in the 296 
plasticity zone as indicators of pathogenicity for H. pylori infection, in spite of a lack of 297 
credible knowledge regarding the functions of the putatively encoded proteins in this cluster. 298 
It seems that these determinants may play a key role in determining the virulence capacity of 299 
H. pylori strains either directly or by encoding factors that may lead to varying clinical 300 
outcomes. The association between some of the ORFs in the plasticity zone and various 301 
disease categories has been previously reported. For instance, Occhialini et al. (2000) found 302 
that two single ORFs (jhp0940 and jhp0947) were more prevalent in strains isolated from 303 
patients with gastric adenocarcinoma in Costa Rica. However, Santos et al. (2003) showed 304 
the association between jhp0947 and DU as well as GC in Brazilian patients. This was once 305 
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more confirmed for jhp0947 and jhp0949 genes in DU patients from the Netherlands (de 306 
Jonge et al., 2004). 307 
Our study in Southeast Indian population demonstrated that dupA gene was 6.5 times 308 
more prevalent in duodenal ulcer patients than non-ulcer patients. Hence, dupA gene was 309 
significantly associated (P=0.001) with DU. Associations between the presence of dupA and 310 
H. pylori-diseases varies around the world (Nguyen et al., 2009, Argent et al., 2007, Gomes 311 
et al., 2008, Hussein et al., 2010). Several issues starting from geographical variations to 312 
study procedures have to be considered. In some studies, only one set of primer pairs for 313 
jhp0917 and jhp0918 was used (Lu et al., 2005; Zhang et al., 2008; Douraghi et al., 2008; 314 
Pacheco et al., 2008). Our study showed that 13% (5/38) dot blot positive strains for 315 
jhp0917-jhp0918 failed to provide any amplicon by initial set of primers. But later on, 316 
different set of primers yielded amplicons of the same strains. Hence, use of multiple primer 317 
pairs is recommended for detection of the dupA gene in future studies. Besides that, 318 
sequenced based analysis showed that 7.8 % (3/38) jhp0917-jhp0918 positive strains did not 319 
have any insertion of C or T after position 1385 in the 3’region of jhp0917 indicating that 320 
they are not forming the dupA. This report is inconsistent with previous reports in other 321 
populations, which indicated that all clinical isolates possessed a continuous dupA gene 322 
(Douraghi et al., 2008; Schmidt et al., 2008; Gomes et al., 2008). Moreover, in our study not 323 
a single strain was detected with the insertion of T after position 1385 of jhp917. RT-PCR 324 
analysis showed that 20% (7/35) of the dupA positive strains did not show any dupA 325 
transcript. This contradicted the findings of Nguyen et al. (2009) that dupA was always 326 
expressed. Real time PCR analysis showed that expression level of dupA transcript varies 327 
from strain to strain. A recent systematic review study demonstrated the importance of the 328 
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presence of the dupA gene for duodenal ulcer, especially in Asian countries (Shiota et al. 329 
2010). Arachchi et al. (2007) showed that dupA gene was present in 37.5% and 22.8% of 330 
DU and Functional Dyspepsia patients, respectively from North India, but in our study dupA 331 
gene was present in 27.7% and 8.7% of DU and NUD patients, respectively. The reason of 332 
this variation of dupA prevalence in India might be due to the fact that their study did not 333 
include the sequencing of intergenic region of jhp0917-918 to check the insertion of one 334 
nucleotide after position 1385 and RNA expression profile of dupA gene or might be related 335 
to the geographical genome variation of H. pylori as India is a big country with lots of 336 
diversities. Some studies reported that dupA gene have single nucleotide polymorphism 337 
(SNP) that created a premature stop codon and may have considerable effects on protein 338 
expression or function (Gomes et al., 2008; Hussein et al., 2010; Queiroz et al., 2011; 339 
Moura et al., 2012). Moreover, Douraghi et al. (2008) reported that dupA was inversely 340 
associated with the histological feature dysplasia, a main pre-malignant and precancerous 341 
lesion associated with increased incidence of cancer in Iranian population. As a result, dupA 342 
gene may be applicable as a protective marker against GC development. But we were unable 343 
to study this hypothesis as we did not have samples from gastric cancer patients. However, a 344 
very recent study showed that the presence of a complete dupA cluster (type IV secretory 345 
system with vir genes around dupA) seemed to be important in DU development (Jung et al., 346 
2012). 347 
In conclusion, infection with the dupA-positive H. pylori increased the risk for DU 348 
overall and this evidence was significant in Indian study. The gene dupA can be considered 349 
as an important biomarker for DU in Indian population. However, further studies are 350 
required to determine the functionality of dupA and its relationship with disease. The 351 
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discrepancy of dupA association with diseases outcome could be related to the limitation of 352 
PCR techniques for detecting the intact dupA gene or may be a consequence of the plasticity 353 
of H. pylori, which contributes to its genetic diversity and requires additional studies for a 354 
firm conclusion. 355 
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Legends to Figures: 511 
Figure 1: Schematic representation of dupA gene of clinical isolates with reference to strain 512 
j99 having region jhp0917 and jhp0918. Different sets of primers pair with different location 513 
of dupA gene for the amplification of PCR products. 514 
Figure 2: PCR and Dot-Blot Hybridization result (A) Lane1, strain j99 act as a positive 515 
control having amplicon size 307bp, lane 2-8 clinical isolates. (B) Lane 1strain J99 act as 516 
positive control 2, 5, 6 shows negative result by PCR but these same strains shows positive 517 
result by Dot-Blot Hybridization. 518 
Figure 3: Nucleotide sequences alignment of partial sequences of dupA from position 519 
1355bp to 1406bp, start codon of dupA gene is taken as position1. The asterisks show the 520 
positions where nucleotide sequences match and the hyphens represent deletions. Alignment 521 
was done by CLUSTAL 2.0.12 multiple sequence alignment tool. Shaded part shows 522 
variation. 523 
Fig 4.  524 
(A)  Semiquantitative RT-PCR analysis of dupA gene of representative strains from 525 
India. 1
st
 lane: 100bp marker. Lane 2-5 and lane 8-9 showed that dupA transcript was 526 
present but lanes 6-7 reflected absence of dupA transcript.  527 
(B)   dupA mRNA expression was analyzed in triplicate sample by qRT-PCR and data 528 
presented as mean (S.D). Relative expression (rpsT normalized) of dupA gene in 529 
strains I-114, 217(4b), san77, 127(1a) compared with strain I-77. 530 
531 
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Table 1: Primers used for the amplification and sequencing of dupA gene. 532 
Primer Sequence (5'-3') Size (bp) Annealing 
temp.(°C) 
Reference 
Jhp0917F 
Jhp0917R 
 
Jhp0918F 
Jhp0918R 
 
ureBF 
ureBR 
 
set5F 
set5R 
 
DupA setIF 
DupAsetIR 
 
rpsTF 
rpsTR 
 
DupAsetIIF 
DupAsetIR 
 
DupAsetIIF 
Jhp0918R 
 
DupA setIF 
DupAR 
 
cagA5cf 
cagA3cR 
TGGTTTCTACTGACAGAGCGC  
AACACGCTGACAGGACAATCTCCC 
 
CCTATATCGCTAACGCGCGCTC  
AAGCTGAAGCGTTTGTAACG 
CGTCCGGCAATAGCTGCCATAGT 
GTAGGTCCTGCTACTGAAGCCTTA 
 
CTAGCGAACAAGATTTTAATGAGAT 
CCTAATTCTTTGACTTGAGATATT 
 
CGTGATCAATATGGATGCTT  
GCAAAGTGTTCCGTTGATCT 
 
GGCAAATCATAAGTCCGCAGAA 
CTTTCCTAGAAGCGGTGTTTTTCT 
 
GGGAGATTGTCCTGTCAGCGTG 
GCAAAGTGTTCCGTTGATCT 
 
GGGAGATTGTCCTGTCAGCGTG 
AAGCTGAAGCGTTTGTAACG 
CGTGATCAATATGGATGCTT 
TTAAATACTCTTCCTTATAAGT 
 
GTTGATAACGCTGTCGCTTCA 
GGGTTGTATGATATTTTCCATAA 
307 
 
276 
 
480 
 
350 
 
214 
 
217 
 
805 
 
1022 
 
563 
 
350 
55 
 
55 
 
50 
 
 
56 
 
 
 
54 
 
 
55 
 
 
58 
 
 
55 
 
 
50 
 
 
55 
Lu et al.(2005) 
 
Lu et al.(2005) 
 
This study 
 
 
This study 
 
 
 
Gomes et al (2008) 
 
 
This study 
 
This study 
 
 
This study 
 
 
 
This study 
 
 
Chattopadhyay et al 
(2004) 
 533 
Table 2: Prevalence of dupA, cagA and vacA genes among the studied strains in India 534 
 535 
 Total DU NUD 
Number 
 
140 83 57  
dupA 28 (20%) 23 (27.7%) 5 (8.7%) 
cagA 129 (92.1%)  76 (91.5%) 53 (92.9%) 
vacA s1m1 98 (70%)  
 
59 (71%) 39 (68.4%) 
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